Actinium Pharmaceuticals (ATNM) Q1 2024 Earnings
ATNM·Reported April 26, 2024·Before market open
Diluted EPS came in at $-0.31, beat the $-0.42 consensus by $0.11.
Diluted EPS
$-0.31beat by $0.11
Consensus: $-0.42
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Actinium Pharmaceuticals's Q1 2024 earnings report.
Actinium Pharmaceuticals (ATNM) reported Q1 2024 earnings on April 26, 2024 before market open.
Actinium Pharmaceuticals reported diluted EPS of $-0.31 for Q1 2024.
EPS beat the consensus estimate of $-0.42 by $0.11.
You can read the 10-Q periodic report (0001213900-24-036699) directly on SEC EDGAR. The filing index links above go to sec.gov.